1-9 of 9
Mehmet Kocoglu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 2 registrational study of anitocabtagene autoleucel for the treatment of patients with relapsed and/or refractory multiple myeloma: Updated results from iMMagine–1

Free
Krina Patel, Binod Dhakal, Gurbakhash Kaur, Richard Maziarz, Natalie Callander, Adam Sperling, Carolina Schinke, Andrzej Jakubowiak, Noa Biran, Douglas Sborov, Cindy Varga, Larry Anderson, Abhinav Deol, Abraham Kanate, Mehmet Kocoglu, Melhem Solh, Kamalika Banerjee, Krishna Rana, Ana Kostic, Enrique Granados, Carolyn Jackson, Christopher Heery, Ciara Louise Freeman, Tim Welliver, Matthew Frigault
Journal: Blood
Blood (2025) 146 (Supplement 1): 256.
https://doi.org/10.1182/blood-2025-256
Published: 2025
Journal Articles

Rehabilitation needs and predictors of functional outcomes following CAR T-cell therapy in lymphoma and multiple myeloma

Free
Hanan Alharthy, Abdulaziz Abu Haimed, Haroon Ahmad, Renu Thomas, Melissa Nicholas, Faisal Abushullaih, Emily Davidson, Graeme Fenton, Justin Kehm, Aaron Rapoport, Jean Yared, Ariel Fromowitz, Mehmet Kocoglu, Djordje Atanackovic, Nancy Hardy, Ashraf Badros
Journal: Blood
Blood (2025) 146 (Supplement 1): 6289.
https://doi.org/10.1182/blood-2025-6289
Published: 2025
Journal Articles

Outcomes of stem cell boost (SCB) versus supportive care alone for prolonged cytopenias after chimeric antigen receptor T cell therapy (CAR-T) in relapsed/refractory multiple myeloma (RRMM): A muli-center real-world analysis

Free
Cindy Varga, Myra Robinson, James Davis, Hamza Hashmi, Thomas Martin, Anupama Kumar, Douglas Sborov, Charlotte Wagner, Doris Hansen, Omar Alexis Castaneda Puglianini, Leyla Shune, Evguenia Bhurtel, Aimaz Afrough, Larry Anderson, Binod Dhakal, Megan Herr, Shambavi Richard, Alex Lieberman-Cribbin, Daniel Sherbenou, Peter Forsberg, Sneha Purvey, Jack Khouri, Yi Lin, Surbhi Sidana, Shonali Midha, Asad Haider, Krina Patel, Mehmet Kocoglu, Christopher Ferreri
Journal: Blood
Blood (2025) 146 (Supplement 1): 1035.
https://doi.org/10.1182/blood-2025-1035
Published: 2025
Journal Articles

Atypical neurotoxicity in CAR-T cell therapy: A retrospective analysis of unusual icans presentations and their clinical implications

Free
Melissa Nicholas, Abdulaziz Abu Haimed, Faisal Abushullaih, Emily Davidson, Graeme Fenton, Justin Kehm, Mehmet Kocoglu, Jean Yared, Ariel Fromowitz, Nancy Hardy, Aaron Rapoport, Djordje Atanackovic, Ashraf Badros, Haroon Ahmad
Journal: Blood
Blood (2025) 146 (Supplement 1): 4151.
https://doi.org/10.1182/blood-2025-4151
Published: 2025
Journal Articles

Tri-specific autologous CD19.20.22 chimeric antigen receptor (CAR) T-cells for patients with Relapsed/Refractory B-cell lymphomas.

Free
Samuel Weeks, Aerielle Matsangos, Daniel Yamoah, Rediet Mulatu, Ariel Fromowitz, Nancy Hardy, Jean Yared, Louisa Wirthin, Pradyot Dash, Natalie McNally, John Braxton, Nikhil-Reddy Varakala, Xiaoxuan Fan, Sharon Hancock, Brandon Cooper, Mehmet Kocoglu, Kim Hankey, Aaron Rapoport, Djordje Atanackovic
Journal: Blood
Blood (2025) 146 (Supplement 1): 4145.
https://doi.org/10.1182/blood-2025-4145
Published: 2025
Journal Articles

Impact and predictors of icans on survival in lymphoma and myeloma patients treated with CAR T cell therapy

Free
Abdulaziz Abu-Haimed, Olga Goloubeva, Haroon Ahmad, Faisal Abushullaih, Melissa Nicholas, Hanan Alharthy, Emily Davidson, Graeme Fenton, Justin Kehm, Aaron Rapoport, Jean Yared, Nancy Hardy, Ariel Fromowitz, Mehmet Kocoglu, Djordje Atanackovic, Ashraf Badros
Journal: Blood
Blood (2025) 146 (Supplement 1): 5928.
https://doi.org/10.1182/blood-2025-5928
Published: 2025
Journal Articles

Vaccine-induced T-cell responses against SARS-CoV-2 and its Omicron variant in patients with B cell–depleted lymphoma after CART therapy

Free
Clinical Trials & Observations
Djordje Atanackovic, Tim Luetkens, Destiny Omili, Thierry Iraguha, Forat Lutfi, Nancy M. Hardy, Xiaoxuan Fan, Stephanie V. Avila, Kapil K. Saharia, Jennifer S. Husson, Silke V. Niederhaus, Philip Margiotta, Seung T. Lee, Jennie Y. Law, Heather D. Mannuel, Erica Vander Mause, Sherri Bauman, Patricia Lesho, Kim Hankey, John Baddley, Mehmet Kocoglu, Jean A. Yared, Aaron P. Rapoport, Saurabh Dahiya
Journal: Blood
Blood (2022) 140 (2): 152–156.
https://doi.org/10.1182/blood.2022016175
Published: 2022
Includes: Supplemental data
Journal Articles

Pembrolizumab, pomalidomide, and low-dose dexamethasone for relapsed/refractory multiple myeloma

Free
Clinical Trials & Observations
Ashraf Badros, Elizabeth Hyjek, Ning Ma, Alexander Lesokhin, Ahmet Dogan, Aaron P. Rapoport, Mehmet Kocoglu, Emily Lederer, Sunita Philip, Todd Milliron, Cameron Dell, Olga Goloubeva, Zeba Singh
Journal: Blood
Blood (2017) 130 (10): 1189–1197.
https://doi.org/10.1182/blood-2017-03-775122
Published: 2017
Includes: Supplemental data
Journal Articles

Clinical and pharmacodynamic analysis of pomalidomide dosing strategies in myeloma: impact of immune activation and cereblon targets

Free
Kartik Sehgal, Rituparna Das, Lin Zhang, Rakesh Verma, Yanhong Deng, Mehmet Kocoglu, Juan Vasquez, Srinivas Koduru, Yan Ren, Maria Wang, Suzana Couto, Mike Breider, Donna Hansel, Stuart Seropian, Dennis Cooper, Anjan Thakurta, Xiaopan Yao, Kavita M. Dhodapkar, Madhav V. Dhodapkar
Journal: Blood
Blood (2015) 125 (26): 4042–4051.
https://doi.org/10.1182/blood-2014-11-611426
Published: 2015
Includes: Supplemental data